Liver initiation activity of norfloxacin but not nalidixic acid, pipemidic acid, and ciprofloxacin on in vivo short-term liver initiation assay in rats.
This study aimed to examine the in vivo initiation activity of the quinolone antimicrobials--nalidixic acid (NA), pipemidic acid (PPA), ciprofloxacin (CPFX), and norfloxacin (NFLX)--by using an in vivo short-term liver initiation assay. Rats were subjected to a two-thirds partial hepatectomy on day 0 and 12 h after completion of this procedure were treated once orally with each quinolone or vehicle. Subsequently, they were fed a basal diet for 14 days and a diet containing 0.015% of 2-acetylaminofluorene for the following 10 days. On day 19, a single oral dose of carbon tetrachloride at 0.8 mL/kg body weight was administered. On day 34, they were sacrificed under ether anesthesia, and liver slices were fixed in 10% neutral buffered formalin for immunohistochemical examination of glutathione S-transferase placental form (GST-P) positive foci. Administration of NFLX resulted in a significant increase in the mean number and area of GST-P positive foci; however, administration of the three other quinolones did not produce any increase. These results suggest that only NFLX has an initiation activity in rats under the conditions used in the present study.
Laboratory of Veterinary Pathology, Faculty of Agriculture, Tokyo University of Agriculture and Technology, 3-5-8 Saiwai-cho, Fuchu, Tokyo 183-8509, Japan. kakuitou@yahoo.co.jp
Tadashi
T
Itoh
Mitsuyoshi
M
Moto
Miwa
M
Takahashi
Hiroki
H
Sakai
Kunitoshi
K
Mitsumori
D015073:2-Acetylaminofluorene / Q000633:toxicity; D000818:Animals; D000890:Anti-Infective Agents / Q000633:toxicity*; D002251:Carbon Tetrachloride / Q000633:toxicity; D002273:Carcinogens / Q000633:toxicity; D002939:Ciprofloxacin / Q000633:toxicity; D005982:Glutathione Transferase / Q000378:metabolism; D008099:Liver / Q000187:drug effects* / Q000378:metabolism / Q000473:pathology; D008297:Male; D009268:Nalidixic Acid / Q000633:toxicity; D009643:Norfloxacin / Q000633:toxicity*; D010876:Pipemidic Acid / Q000633:toxicity; D051381:Rats; D011916:Rats, Inbred F344
D000890:Anti-Infective Agents; D002273:Carcinogens; D009268:Nalidixic Acid; D002939:Ciprofloxacin; D015073:2-Acetylaminofluorene; D002251:Carbon Tetrachloride; D005982:Glutathione Transferase; D010876:Pipemidic Acid; D009643:Norfloxacin